Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 9.41430913 |
2 | regulation of guanylate cyclase activity (GO:0031282) | 8.15861556 |
3 | lipoprotein transport (GO:0042953) | 7.79555397 |
4 | NADH metabolic process (GO:0006734) | 7.51886583 |
5 | epoxygenase P450 pathway (GO:0019373) | 7.18023859 |
6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 7.09021929 |
7 | indole-containing compound catabolic process (GO:0042436) | 6.67288581 |
8 | indolalkylamine catabolic process (GO:0046218) | 6.67288581 |
9 | tryptophan catabolic process (GO:0006569) | 6.67288581 |
10 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.40217700 |
11 | aromatic amino acid family catabolic process (GO:0009074) | 6.33818621 |
12 | tryptophan metabolic process (GO:0006568) | 6.25087225 |
13 | hormone catabolic process (GO:0042447) | 6.00212059 |
14 | L-phenylalanine catabolic process (GO:0006559) | 5.90474612 |
15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.90474612 |
16 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.90023861 |
17 | endocrine process (GO:0050886) | 5.90023861 |
18 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.90023861 |
19 | kynurenine metabolic process (GO:0070189) | 5.87486288 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.71214304 |
21 | L-phenylalanine metabolic process (GO:0006558) | 5.71214304 |
22 | drug transmembrane transport (GO:0006855) | 5.39364680 |
23 | virion attachment to host cell (GO:0019062) | 5.33648480 |
24 | adhesion of symbiont to host cell (GO:0044650) | 5.33648480 |
25 | lysine metabolic process (GO:0006553) | 5.32094427 |
26 | lysine catabolic process (GO:0006554) | 5.32094427 |
27 | regulation of systemic arterial blood pressure (GO:0003073) | 5.30092232 |
28 | drug metabolic process (GO:0017144) | 5.25653606 |
29 | homocysteine metabolic process (GO:0050667) | 5.25300454 |
30 | cysteine metabolic process (GO:0006534) | 5.10401624 |
31 | glyoxylate metabolic process (GO:0046487) | 5.09988252 |
32 | regulation of bile acid biosynthetic process (GO:0070857) | 5.04044168 |
33 | regulation of cGMP biosynthetic process (GO:0030826) | 4.95589237 |
34 | peptide hormone processing (GO:0016486) | 4.94917530 |
35 | urate metabolic process (GO:0046415) | 4.89849548 |
36 | sulfur amino acid catabolic process (GO:0000098) | 4.89716716 |
37 | amine catabolic process (GO:0009310) | 4.85396892 |
38 | cellular biogenic amine catabolic process (GO:0042402) | 4.85396892 |
39 | diacylglycerol metabolic process (GO:0046339) | 4.84448677 |
40 | regulation of cellular extravasation (GO:0002691) | 4.81642850 |
41 | indolalkylamine metabolic process (GO:0006586) | 4.80624759 |
42 | * bile acid and bile salt transport (GO:0015721) | 4.80217886 |
43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.77829770 |
44 | peptide catabolic process (GO:0043171) | 4.77482542 |
45 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.75821777 |
46 | bile acid biosynthetic process (GO:0006699) | 4.61612164 |
47 | aromatic amino acid family metabolic process (GO:0009072) | 4.59882192 |
48 | drug transport (GO:0015893) | 4.56389142 |
49 | adhesion of symbiont to host (GO:0044406) | 4.52867285 |
50 | drug catabolic process (GO:0042737) | 4.52825013 |
51 | digestion (GO:0007586) | 4.49082665 |
52 | plasma lipoprotein particle assembly (GO:0034377) | 4.42627789 |
53 | renal system process involved in regulation of blood volume (GO:0001977) | 4.42316690 |
54 | amino-acid betaine metabolic process (GO:0006577) | 4.37437620 |
55 | urea metabolic process (GO:0019627) | 4.35795318 |
56 | urea cycle (GO:0000050) | 4.35795318 |
57 | * bile acid metabolic process (GO:0008206) | 4.34794700 |
58 | glycolipid catabolic process (GO:0019377) | 4.32945162 |
59 | cellular response to nitric oxide (GO:0071732) | 4.32877851 |
60 | glycosphingolipid catabolic process (GO:0046479) | 4.28544428 |
61 | cellular glucuronidation (GO:0052695) | 4.26153218 |
62 | vitamin A metabolic process (GO:0006776) | 4.16482601 |
63 | regulation of vitamin metabolic process (GO:0030656) | 4.15162080 |
64 | vitamin transmembrane transport (GO:0035461) | 4.14741247 |
65 | serine family amino acid catabolic process (GO:0009071) | 4.14659387 |
66 | regulation of cGMP metabolic process (GO:0030823) | 4.13751491 |
67 | cellular ketone body metabolic process (GO:0046950) | 4.13742922 |
68 | drinking behavior (GO:0042756) | 4.13505950 |
69 | benzene-containing compound metabolic process (GO:0042537) | 4.08578758 |
70 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.05602851 |
71 | vitamin transport (GO:0051180) | 4.02692927 |
72 | alkaloid metabolic process (GO:0009820) | 4.01549587 |
73 | protein-lipid complex assembly (GO:0065005) | 4.00833494 |
74 | alpha-amino acid catabolic process (GO:1901606) | 3.97585050 |
75 | nitrogen cycle metabolic process (GO:0071941) | 3.97291607 |
76 | exogenous drug catabolic process (GO:0042738) | 3.94848809 |
77 | glucuronate metabolic process (GO:0019585) | 3.94488225 |
78 | uronic acid metabolic process (GO:0006063) | 3.94488225 |
79 | fat-soluble vitamin metabolic process (GO:0006775) | 3.93509661 |
80 | alpha-linolenic acid metabolic process (GO:0036109) | 3.89978120 |
81 | complement activation, alternative pathway (GO:0006957) | 3.85761730 |
82 | glutamate metabolic process (GO:0006536) | 3.83205317 |
83 | antibacterial humoral response (GO:0019731) | 3.79097637 |
84 | high-density lipoprotein particle remodeling (GO:0034375) | 3.77327251 |
85 | regulation of protein activation cascade (GO:2000257) | 3.76584714 |
86 | tyrosine metabolic process (GO:0006570) | 3.76312778 |
87 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.74950913 |
88 | protein carboxylation (GO:0018214) | 3.74950913 |
89 | cellular amino acid catabolic process (GO:0009063) | 3.74912722 |
90 | response to nitric oxide (GO:0071731) | 3.73399052 |
91 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.70458419 |
92 | antimicrobial humoral response (GO:0019730) | 3.68175596 |
93 | short-chain fatty acid metabolic process (GO:0046459) | 3.67000961 |
94 | cellular response to reactive nitrogen species (GO:1902170) | 3.66002948 |
95 | cGMP biosynthetic process (GO:0006182) | 3.65614736 |
96 | phospholipid efflux (GO:0033700) | 3.64566053 |
97 | coenzyme catabolic process (GO:0009109) | 3.63455749 |
98 | cellular modified amino acid catabolic process (GO:0042219) | 3.61728992 |
99 | triglyceride homeostasis (GO:0070328) | 3.61245394 |
100 | acylglycerol homeostasis (GO:0055090) | 3.61245394 |
101 | intestinal absorption (GO:0050892) | 3.58947475 |
102 | indole-containing compound metabolic process (GO:0042430) | 3.58833247 |
103 | NAD biosynthetic process (GO:0009435) | 3.56728492 |
104 | carnitine metabolic process (GO:0009437) | 3.56319411 |
105 | phospholipid homeostasis (GO:0055091) | 3.55065700 |
106 | protein-lipid complex remodeling (GO:0034368) | 3.53821376 |
107 | macromolecular complex remodeling (GO:0034367) | 3.53821376 |
108 | plasma lipoprotein particle remodeling (GO:0034369) | 3.53821376 |
109 | ketone body metabolic process (GO:1902224) | 3.53095566 |
110 | intestinal cholesterol absorption (GO:0030299) | 3.53051069 |
111 | flavonoid metabolic process (GO:0009812) | 3.52737868 |
112 | regulation of complement activation (GO:0030449) | 3.50141355 |
113 | organic cation transport (GO:0015695) | 3.49629640 |
114 | cobalamin metabolic process (GO:0009235) | 3.49035964 |
115 | vitamin biosynthetic process (GO:0009110) | 3.48859920 |
116 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.48266837 |
117 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.47627676 |
118 | fructose metabolic process (GO:0006000) | 3.47352184 |
119 | ceramide catabolic process (GO:0046514) | 3.46864341 |
120 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.46421683 |
121 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45108508 |
122 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45108508 |
123 | negative regulation of sterol transport (GO:0032372) | 3.43429325 |
124 | negative regulation of cholesterol transport (GO:0032375) | 3.43429325 |
125 | aspartate family amino acid catabolic process (GO:0009068) | 3.42362537 |
126 | regulation of cholesterol esterification (GO:0010872) | 3.41352333 |
127 | 2-oxoglutarate metabolic process (GO:0006103) | 3.40510122 |
128 | reverse cholesterol transport (GO:0043691) | 3.39570172 |
129 | vitamin D metabolic process (GO:0042359) | 3.38816558 |
130 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38211619 |
131 | regulation of triglyceride catabolic process (GO:0010896) | 3.38196602 |
132 | cGMP-mediated signaling (GO:0019934) | 3.36414809 |
133 | positive regulation of pseudopodium assembly (GO:0031274) | 3.35900720 |
134 | serine family amino acid metabolic process (GO:0009069) | 3.35458881 |
135 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.35142208 |
136 | regulation of fibrinolysis (GO:0051917) | 3.35141577 |
137 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.34307981 |
138 | glycosylceramide metabolic process (GO:0006677) | 3.34126481 |
139 | carboxylic acid catabolic process (GO:0046395) | 3.33382782 |
140 | organic acid catabolic process (GO:0016054) | 3.33382782 |
141 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.30020789 |
142 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.30020789 |
143 | fatty acid beta-oxidation (GO:0006635) | 3.29902066 |
144 | fatty acid oxidation (GO:0019395) | 3.29594489 |
145 | acetyl-CoA metabolic process (GO:0006084) | 3.29271453 |
146 | negative regulation of fibrinolysis (GO:0051918) | 3.28314620 |
147 | positive regulation of lipid catabolic process (GO:0050996) | 3.27747075 |
148 | mRNA modification (GO:0016556) | 3.26669838 |
149 | sphingolipid catabolic process (GO:0030149) | 3.25366312 |
150 | lipid oxidation (GO:0034440) | 3.25032677 |
151 | arginine metabolic process (GO:0006525) | 3.22812452 |
152 | glycerol metabolic process (GO:0006071) | 3.21966913 |
153 | positive regulation of cGMP metabolic process (GO:0030825) | 3.21953651 |
154 | midgut development (GO:0007494) | 3.20414700 |
155 | lipoprotein metabolic process (GO:0042157) | 3.17353369 |
156 | L-ascorbic acid metabolic process (GO:0019852) | 3.15742332 |
157 | cholesterol efflux (GO:0033344) | 3.14924137 |
158 | digestive system process (GO:0022600) | 3.14287589 |
159 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.13314013 |
160 | phenol-containing compound catabolic process (GO:0019336) | 3.13252038 |
161 | sphingomyelin metabolic process (GO:0006684) | 3.12438928 |
162 | membrane lipid catabolic process (GO:0046466) | 3.12352399 |
163 | glomerulus development (GO:0032835) | 3.12336174 |
164 | sulfate transmembrane transport (GO:1902358) | 3.12177759 |
165 | regulation of cholesterol homeostasis (GO:2000188) | 3.11685295 |
166 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.11427338 |
167 | leukotriene metabolic process (GO:0006691) | 3.11403153 |
168 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11011198 |
169 | sexual reproduction (GO:0019953) | 3.09408557 |
170 | response to phenylpropanoid (GO:0080184) | 3.09080021 |
171 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.08649345 |
172 | transepithelial transport (GO:0070633) | 3.08488642 |
173 | actin filament depolymerization (GO:0030042) | 3.07081376 |
174 | response to nitrosative stress (GO:0051409) | 3.06853227 |
175 | imidazole-containing compound metabolic process (GO:0052803) | 3.05590162 |
176 | sterol homeostasis (GO:0055092) | 3.05356803 |
177 | angiotensin maturation (GO:0002003) | 12.4150152 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.98696416 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.31664539 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.12788123 |
4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.40394430 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.34315417 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.43962715 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.31894886 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.01003686 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.94380958 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91899272 |
11 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.50804523 |
12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.44658152 |
13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.44253432 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.37436472 |
15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.26023844 |
16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.95792747 |
17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.95304538 |
18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93289729 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88809567 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82745755 |
21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.79023018 |
22 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.76355525 |
23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65331497 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63408503 |
25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61300668 |
26 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58442874 |
27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58242089 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54812650 |
29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54215606 |
30 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52149310 |
31 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.51671770 |
32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51657093 |
33 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.46152925 |
34 | * GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42984955 |
35 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42824719 |
36 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41413000 |
37 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41005622 |
38 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40331917 |
39 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40055677 |
40 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37931395 |
41 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.35593646 |
42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34436291 |
43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32988751 |
44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.32587013 |
45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32355705 |
46 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31760707 |
47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.31151684 |
48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30318394 |
49 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29627497 |
50 | GATA2_19941826_ChIP-Seq_K562_Human | 1.26862490 |
51 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.26400979 |
52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24654191 |
53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24383073 |
54 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.24163205 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22378608 |
56 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22347310 |
57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18428477 |
58 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18212800 |
59 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18199557 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18089175 |
61 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17899581 |
62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16806742 |
63 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15107692 |
64 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15100512 |
65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14572543 |
66 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13716730 |
67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13258099 |
68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13132764 |
69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12572032 |
70 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12048190 |
71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11682661 |
72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10886965 |
73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09608883 |
74 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.09419707 |
75 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08300428 |
76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.08162716 |
77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.08162716 |
78 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07714408 |
79 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07643214 |
80 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.07449819 |
81 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07405706 |
82 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07259269 |
83 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06431576 |
84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06024535 |
85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05440096 |
86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05240891 |
87 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04881649 |
88 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04152881 |
89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04073287 |
90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03686762 |
91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03085725 |
92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.02648002 |
93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02501296 |
94 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02174259 |
95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01917228 |
96 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01516013 |
97 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01250097 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01232015 |
99 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00446168 |
100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00105630 |
101 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00037852 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99601778 |
103 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99541134 |
104 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99091793 |
105 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.98339964 |
106 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98111271 |
107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97968469 |
108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97621179 |
109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95913764 |
110 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95768973 |
111 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95585700 |
112 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95397271 |
113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.94902284 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.94542257 |
115 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94319884 |
116 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93957737 |
117 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.93779971 |
118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93735818 |
119 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93606390 |
120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92750389 |
121 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.91331508 |
122 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91041159 |
123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90272758 |
124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90088748 |
125 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90082577 |
126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89784881 |
127 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.89440300 |
128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89404396 |
129 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88443000 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88248391 |
131 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.87178608 |
132 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.87094684 |
133 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87022550 |
134 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.87008643 |
135 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86532284 |
136 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86217797 |
137 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.86215863 |
138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.86214549 |
139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.86152043 |
140 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85552137 |
141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85530047 |
142 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.85365333 |
143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84910200 |
144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84855665 |
145 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84579583 |
146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84488420 |
147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.83963376 |
148 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83763198 |
149 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83757503 |
150 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83000116 |
151 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.82621999 |
152 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82491842 |
153 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.81811784 |
154 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81439084 |
155 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.81052199 |
156 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80835511 |
157 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80674378 |
158 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.79939030 |
159 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79465802 |
160 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79298527 |
161 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79250593 |
162 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78530735 |
163 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.77114414 |
164 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76675050 |
165 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76119061 |
166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75650545 |
167 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.75643549 |
168 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75643295 |
169 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.75505761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.76544731 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.94017913 |
3 | * MP0005085_abnormal_gallbladder_physiolo | 5.34790721 |
4 | * MP0005365_abnormal_bile_salt | 5.15186992 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.49819719 |
6 | MP0003252_abnormal_bile_duct | 4.05005523 |
7 | MP0009379_abnormal_foot_pigmentation | 3.86453878 |
8 | MP0004019_abnormal_vitamin_homeostasis | 3.17350423 |
9 | MP0005332_abnormal_amino_acid | 3.11583931 |
10 | MP0003195_calcinosis | 3.08532714 |
11 | MP0010329_abnormal_lipoprotein_level | 2.80294050 |
12 | MP0003806_abnormal_nucleotide_metabolis | 2.73425456 |
13 | MP0002138_abnormal_hepatobiliary_system | 2.72871537 |
14 | * MP0001666_abnormal_nutrient_absorption | 2.59732510 |
15 | MP0010234_abnormal_vibrissa_follicle | 2.55249697 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.39031582 |
17 | MP0005409_darkened_coat_color | 2.30767620 |
18 | MP0002876_abnormal_thyroid_physiology | 2.18541572 |
19 | MP0009643_abnormal_urine_homeostasis | 1.98133339 |
20 | MP0000490_abnormal_crypts_of | 1.85293304 |
21 | MP0009697_abnormal_copulation | 1.84868710 |
22 | MP0004043_abnormal_pH_regulation | 1.83645973 |
23 | * MP0002118_abnormal_lipid_homeostasis | 1.61342908 |
24 | MP0005636_abnormal_mineral_homeostasis | 1.59115226 |
25 | MP0005319_abnormal_enzyme/_coenzyme | 1.54987874 |
26 | * MP0000609_abnormal_liver_physiology | 1.54727172 |
27 | MP0001764_abnormal_homeostasis | 1.53943480 |
28 | MP0003878_abnormal_ear_physiology | 1.53829780 |
29 | MP0005377_hearing/vestibular/ear_phenot | 1.53829780 |
30 | MP0009840_abnormal_foam_cell | 1.52607269 |
31 | MP0001188_hyperpigmentation | 1.52349810 |
32 | MP0000678_abnormal_parathyroid_gland | 1.50815767 |
33 | MP0005083_abnormal_biliary_tract | 1.50513203 |
34 | MP0010352_gastrointestinal_tract_polyps | 1.50089619 |
35 | MP0005084_abnormal_gallbladder_morpholo | 1.47179903 |
36 | MP0004264_abnormal_extraembryonic_tissu | 1.47043020 |
37 | * MP0003868_abnormal_feces_composition | 1.45532511 |
38 | MP0005451_abnormal_body_composition | 1.44314825 |
39 | MP0000538_abnormal_urinary_bladder | 1.40646389 |
40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.34664769 |
41 | MP0009764_decreased_sensitivity_to | 1.34279815 |
42 | MP0001765_abnormal_ion_homeostasis | 1.30713490 |
43 | MP0002822_catalepsy | 1.29826977 |
44 | MP0005670_abnormal_white_adipose | 1.29740057 |
45 | MP0004270_analgesia | 1.26954076 |
46 | MP0001501_abnormal_sleep_pattern | 1.26759383 |
47 | MP0001756_abnormal_urination | 1.23290703 |
48 | MP0004147_increased_porphyrin_level | 1.23121354 |
49 | MP0002136_abnormal_kidney_physiology | 1.20097580 |
50 | MP0000566_synostosis | 1.20018652 |
51 | MP0003186_abnormal_redox_activity | 1.05371117 |
52 | MP0002396_abnormal_hematopoietic_system | 0.98343785 |
53 | MP0002971_abnormal_brown_adipose | 0.98192876 |
54 | MP0004782_abnormal_surfactant_physiolog | 0.95995755 |
55 | MP0004858_abnormal_nervous_system | 0.93871279 |
56 | MP0005647_abnormal_sex_gland | 0.93739159 |
57 | MP0002277_abnormal_respiratory_mucosa | 0.90183252 |
58 | MP0008469_abnormal_protein_level | 0.88799184 |
59 | MP0003724_increased_susceptibility_to | 0.85091009 |
60 | MP0010155_abnormal_intestine_physiology | 0.83799476 |
61 | MP0009115_abnormal_fat_cell | 0.83784729 |
62 | * MP0009642_abnormal_blood_homeostasis | 0.83657047 |
63 | MP0002928_abnormal_bile_duct | 0.81259486 |
64 | MP0000537_abnormal_urethra_morphology | 0.74033119 |
65 | MP0000598_abnormal_liver_morphology | 0.72685245 |
66 | MP0001664_abnormal_digestion | 0.72003150 |
67 | MP0005408_hypopigmentation | 0.70791486 |
68 | MP0001663_abnormal_digestive_system | 0.70780835 |
69 | MP0002796_impaired_skin_barrier | 0.70148514 |
70 | MP0001873_stomach_inflammation | 0.68683819 |
71 | MP0005535_abnormal_body_temperature | 0.68571648 |
72 | MP0003183_abnormal_peptide_metabolism | 0.67489978 |
73 | MP0001485_abnormal_pinna_reflex | 0.67419250 |
74 | MP0005666_abnormal_adipose_tissue | 0.66912130 |
75 | MP0005174_abnormal_tail_pigmentation | 0.65770061 |
76 | MP0009763_increased_sensitivity_to | 0.65271137 |
77 | MP0005220_abnormal_exocrine_pancreas | 0.65199884 |
78 | MP0001661_extended_life_span | 0.63352058 |
79 | MP0000249_abnormal_blood_vessel | 0.60726642 |
80 | MP0008872_abnormal_physiological_respon | 0.60484930 |
81 | MP0009765_abnormal_xenobiotic_induced | 0.60003244 |
82 | MP0000230_abnormal_systemic_arterial | 0.59775092 |
83 | MP0000465_gastrointestinal_hemorrhage | 0.59703905 |
84 | MP0006138_congestive_heart_failure | 0.59261799 |
85 | MP0005381_digestive/alimentary_phenotyp | 0.58561718 |
86 | MP0002078_abnormal_glucose_homeostasis | 0.58490558 |
87 | MP0003866_abnormal_defecation | 0.58450768 |
88 | MP0005166_decreased_susceptibility_to | 0.58064407 |
89 | MP0002132_abnormal_respiratory_system | 0.57758721 |
90 | MP0005501_abnormal_skin_physiology | 0.57207071 |
91 | MP0001845_abnormal_inflammatory_respons | 0.56946308 |
92 | MP0000015_abnormal_ear_pigmentation | 0.56845898 |
93 | MP0005334_abnormal_fat_pad | 0.56767510 |
94 | MP0002166_altered_tumor_susceptibility | 0.55339876 |
95 | MP0005464_abnormal_platelet_physiology | 0.54482864 |
96 | MP0008260_abnormal_autophagy | 0.53923229 |
97 | MP0005448_abnormal_energy_balance | 0.51658174 |
98 | MP0001835_abnormal_antigen_presentation | 0.51469009 |
99 | MP0002254_reproductive_system_inflammat | 0.50932051 |
100 | MP0005025_abnormal_response_to | 0.50304998 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.50218149 |
102 | MP0002168_other_aberrant_phenotype | 0.50072171 |
103 | MP0005646_abnormal_pituitary_gland | 0.49580132 |
104 | MP0005395_other_phenotype | 0.48952866 |
105 | MP0004381_abnormal_hair_follicle | 0.48857972 |
106 | MP0000604_amyloidosis | 0.48638650 |
107 | MP0009333_abnormal_splenocyte_physiolog | 0.47701989 |
108 | MP0003953_abnormal_hormone_level | 0.47606625 |
109 | MP0002896_abnormal_bone_mineralization | 0.46720614 |
110 | MP0004947_skin_inflammation | 0.46559055 |
111 | MP0006082_CNS_inflammation | 0.46554241 |
112 | MP0005376_homeostasis/metabolism_phenot | 0.46511096 |
113 | MP0005248_abnormal_Harderian_gland | 0.46444569 |
114 | MP0003303_peritoneal_inflammation | 0.45818134 |
115 | MP0009384_cardiac_valve_regurgitation | 0.45639157 |
116 | MP0010386_abnormal_urinary_bladder | 0.45527163 |
117 | MP0003300_gastrointestinal_ulcer | 0.44578881 |
118 | MP0001881_abnormal_mammary_gland | 0.44352619 |
119 | MP0000462_abnormal_digestive_system | 0.43295027 |
120 | MP0009785_altered_susceptibility_to | 0.42861343 |
121 | MP0002098_abnormal_vibrissa_morphology | 0.42110323 |
122 | MP0002135_abnormal_kidney_morphology | 0.41243370 |
123 | MP0000579_abnormal_nail_morphology | 0.40870627 |
124 | MP0004484_altered_response_of | 0.40777610 |
125 | MP0003011_delayed_dark_adaptation | 0.40252136 |
126 | MP0000516_abnormal_urinary_system | 0.38801182 |
127 | MP0003638_abnormal_response/metabolism_ | 0.37866257 |
128 | MP0003656_abnormal_erythrocyte_physiolo | 0.36915274 |
129 | MP0000477_abnormal_intestine_morphology | 0.36799733 |
130 | MP0003436_decreased_susceptibility_to | 0.35955817 |
131 | MP0003690_abnormal_glial_cell | 0.34975102 |
132 | MP0005058_abnormal_lysosome_morphology | 0.34322609 |
133 | MP0006036_abnormal_mitochondrial_physio | 0.33812784 |
134 | MP0002419_abnormal_innate_immunity | 0.32715640 |
135 | MP0003718_maternal_effect | 0.32351936 |
136 | MP0003879_abnormal_hair_cell | 0.29913386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.95747000 |
2 | Intrahepatic cholestasis (HP:0001406) | 5.75621372 |
3 | Abnormality of vitamin B metabolism (HP:0004340) | 5.57652206 |
4 | Widely patent fontanelles and sutures (HP:0004492) | 5.19597335 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.09914783 |
6 | Conjugated hyperbilirubinemia (HP:0002908) | 4.99425455 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.98534507 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 4.68166624 |
9 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.42145729 |
10 | Hyperglycinuria (HP:0003108) | 4.40667401 |
11 | Hyperactive renin-angiotensin system (HP:0000841) | 4.23729241 |
12 | Deep venous thrombosis (HP:0002625) | 4.16169649 |
13 | Xanthomatosis (HP:0000991) | 4.14607298 |
14 | Pigmentary retinal degeneration (HP:0001146) | 4.13045947 |
15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.13025314 |
16 | Hypobetalipoproteinemia (HP:0003563) | 4.10485282 |
17 | Joint hemorrhage (HP:0005261) | 4.03021648 |
18 | Nausea (HP:0002018) | 3.94820064 |
19 | Metabolic alkalosis (HP:0200114) | 3.93667909 |
20 | Thin bony cortex (HP:0002753) | 3.87294505 |
21 | Wide cranial sutures (HP:0010537) | 3.84396628 |
22 | Abnormality of glycine metabolism (HP:0010895) | 3.82667717 |
23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82667717 |
24 | Hyperammonemia (HP:0001987) | 3.72133107 |
25 | Complement deficiency (HP:0004431) | 3.67016938 |
26 | Ketosis (HP:0001946) | 3.63544683 |
27 | Abnormality of purine metabolism (HP:0004352) | 3.59632238 |
28 | Abnormality of proline metabolism (HP:0010907) | 3.58731677 |
29 | Hydroxyprolinuria (HP:0003080) | 3.58731677 |
30 | Gout (HP:0001997) | 3.51840278 |
31 | * Chronic diarrhea (HP:0002028) | 3.48644776 |
32 | Megaloblastic anemia (HP:0001889) | 3.45457467 |
33 | Hyperglycinemia (HP:0002154) | 3.44986658 |
34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.44927685 |
35 | Alkalosis (HP:0001948) | 3.43593618 |
36 | Facial shape deformation (HP:0011334) | 3.42216372 |
37 | Potter facies (HP:0002009) | 3.42216372 |
38 | Proximal tubulopathy (HP:0000114) | 3.42102902 |
39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36063012 |
40 | Decreased circulating renin level (HP:0003351) | 3.32802187 |
41 | Ketoacidosis (HP:0001993) | 3.25903872 |
42 | Epidermoid cyst (HP:0200040) | 3.25669633 |
43 | * Fat malabsorption (HP:0002630) | 3.24900347 |
44 | Abnormality of chloride homeostasis (HP:0011422) | 3.20974888 |
45 | Hyperlipoproteinemia (HP:0010980) | 3.18688092 |
46 | Hypomagnesemia (HP:0002917) | 3.16213898 |
47 | Vascular calcification (HP:0004934) | 3.15688152 |
48 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.15518578 |
49 | Posterior subcapsular cataract (HP:0007787) | 3.10759159 |
50 | Abdominal distention (HP:0003270) | 3.06988433 |
51 | Tetany (HP:0001281) | 3.04828435 |
52 | Hypolipoproteinemia (HP:0010981) | 3.04478112 |
53 | Congenital sensorineural hearing impairment (HP:0008527) | 3.03818569 |
54 | Hypoglycemic coma (HP:0001325) | 3.02402792 |
55 | Hyperuricemia (HP:0002149) | 3.01680922 |
56 | Increased purine levels (HP:0004368) | 3.01680922 |
57 | Abnormality of methionine metabolism (HP:0010901) | 2.98884004 |
58 | Enlarged epiphyses (HP:0010580) | 2.95640786 |
59 | Metabolic acidosis (HP:0001942) | 2.95492930 |
60 | Increased circulating renin level (HP:0000848) | 2.85290118 |
61 | Abnormal urine phosphate concentration (HP:0012599) | 2.79096251 |
62 | Abnormality of the common coagulation pathway (HP:0010990) | 2.78172284 |
63 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74612179 |
64 | Hyperparathyroidism (HP:0000843) | 2.74042042 |
65 | Delayed epiphyseal ossification (HP:0002663) | 2.73912572 |
66 | Cardiovascular calcification (HP:0011915) | 2.73247018 |
67 | Delayed CNS myelination (HP:0002188) | 2.71102144 |
68 | Hyperbilirubinemia (HP:0002904) | 2.68687501 |
69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.67100565 |
70 | Dicarboxylic aciduria (HP:0003215) | 2.66925972 |
71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.66925972 |
72 | Enlarged kidneys (HP:0000105) | 2.65292335 |
73 | Renal cortical cysts (HP:0000803) | 2.63047701 |
74 | Hypoalphalipoproteinemia (HP:0003233) | 2.60819772 |
75 | Hyperaldosteronism (HP:0000859) | 2.60626639 |
76 | Generalized aminoaciduria (HP:0002909) | 2.60600455 |
77 | Abnormality of renin-angiotensin system (HP:0000847) | 2.59756696 |
78 | Malnutrition (HP:0004395) | 2.59610875 |
79 | Hypoglycemic seizures (HP:0002173) | 2.58616966 |
80 | Hypokalemic alkalosis (HP:0001949) | 2.58268296 |
81 | Abnormal urine output (HP:0012590) | 2.57124697 |
82 | Abnormality of complement system (HP:0005339) | 2.56140804 |
83 | Hyperphosphaturia (HP:0003109) | 2.55180464 |
84 | Systemic lupus erythematosus (HP:0002725) | 2.53815699 |
85 | Abnormality of the intrinsic pathway (HP:0010989) | 2.53786547 |
86 | Abnormality of the costochondral junction (HP:0000919) | 2.51523411 |
87 | Abnormality of renal excretion (HP:0011036) | 2.50490971 |
88 | Polyuria (HP:0000103) | 2.50345809 |
89 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.48742552 |
90 | Abnormality of serum amino acid levels (HP:0003112) | 2.48051560 |
91 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.47651451 |
92 | Villous atrophy (HP:0011473) | 2.47651451 |
93 | Confusion (HP:0001289) | 2.47430806 |
94 | Hypotension (HP:0002615) | 2.47258397 |
95 | Alveolar cell carcinoma (HP:0006519) | 2.45726600 |
96 | Symptomatic seizures (HP:0011145) | 2.41821625 |
97 | Eczematoid dermatitis (HP:0000976) | 2.40747928 |
98 | Renal tubular acidosis (HP:0001947) | 2.36967019 |
99 | Focal segmental glomerulosclerosis (HP:0000097) | 2.36646339 |
100 | Rickets (HP:0002748) | 2.36453002 |
101 | Glycosuria (HP:0003076) | 2.35266481 |
102 | Abnormality of urine glucose concentration (HP:0011016) | 2.35266481 |
103 | Abnormal glucose tolerance (HP:0001952) | 2.32289361 |
104 | Hypercholesterolemia (HP:0003124) | 2.30293630 |
105 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28067139 |
106 | Lethargy (HP:0001254) | 2.26114798 |
107 | Subcapsular cataract (HP:0000523) | 2.25322538 |
108 | Hepatocellular carcinoma (HP:0001402) | 2.24988400 |
109 | Abnormality of vitamin metabolism (HP:0100508) | 2.22340417 |
110 | Poikilocytosis (HP:0004447) | 2.21294749 |
111 | Pancreatitis (HP:0001733) | 2.19888140 |
112 | Hemorrhage of the eye (HP:0011885) | 2.15061749 |
113 | Ileus (HP:0002595) | 2.12496176 |
114 | Myocardial infarction (HP:0001658) | 2.10520311 |
115 | Spontaneous abortion (HP:0005268) | 2.10246535 |
116 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.09708857 |
117 | Hyperphosphatemia (HP:0002905) | 2.09680737 |
118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09671469 |
119 | Vomiting (HP:0002013) | 2.09357375 |
120 | Nephrolithiasis (HP:0000787) | 2.07476466 |
121 | Gingivitis (HP:0000230) | 2.05653251 |
122 | Hypophosphatemic rickets (HP:0004912) | 2.02972731 |
123 | Polydipsia (HP:0001959) | 2.02822072 |
124 | Abnormal drinking behavior (HP:0030082) | 2.02822072 |
125 | Sensorimotor neuropathy (HP:0007141) | 2.00748537 |
126 | Protuberant abdomen (HP:0001538) | 2.00474089 |
127 | Gastrointestinal dysmotility (HP:0002579) | 1.99076715 |
128 | Acanthocytosis (HP:0001927) | 1.98436356 |
129 | Hypophosphatemia (HP:0002148) | 1.98416852 |
130 | Cerebral palsy (HP:0100021) | 1.97247905 |
131 | Hyperventilation (HP:0002883) | 1.96597825 |
132 | Right ventricular cardiomyopathy (HP:0011663) | 1.96330708 |
133 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.95090726 |
134 | Vacuolated lymphocytes (HP:0001922) | 1.94615761 |
135 | Mitral stenosis (HP:0001718) | 1.93894074 |
136 | Multiple lipomas (HP:0001012) | 1.90888011 |
137 | Irritability (HP:0000737) | 1.90067745 |
138 | Renal tubular dysfunction (HP:0000124) | 1.89564828 |
139 | White forelock (HP:0002211) | 1.87661723 |
140 | Growth hormone excess (HP:0000845) | 1.84316540 |
141 | Patchy hypopigmentation of hair (HP:0011365) | 1.81628219 |
142 | Hypocalcemia (HP:0002901) | 1.78122036 |
143 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77889100 |
144 | Paresthesia (HP:0003401) | 1.76408703 |
145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74154203 |
146 | Glomerulosclerosis (HP:0000096) | 1.71786660 |
147 | Metaphyseal irregularity (HP:0003025) | 1.71653485 |
148 | Hypoalbuminemia (HP:0003073) | 1.69758916 |
149 | Abnormal albumin level (HP:0012116) | 1.69758916 |
150 | Dehydration (HP:0001944) | 1.61779001 |
151 | Peripheral demyelination (HP:0011096) | 1.60785068 |
152 | Macrocytic anemia (HP:0001972) | 1.59885889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 9.01004356 |
2 | FRK | 4.91392040 |
3 | WNK3 | 3.97502938 |
4 | MAP3K10 | 3.68318896 |
5 | INSRR | 3.65817961 |
6 | BCKDK | 2.75798326 |
7 | OXSR1 | 2.75695351 |
8 | MAP3K14 | 2.71121475 |
9 | SIK3 | 2.67081253 |
10 | EPHA2 | 2.55012600 |
11 | STK38L | 2.43923564 |
12 | CASK | 2.43426801 |
13 | MST1R | 2.18157770 |
14 | STK39 | 2.05515339 |
15 | SIK1 | 2.04478794 |
16 | AKT3 | 2.01780912 |
17 | TAOK3 | 1.99572011 |
18 | IRAK3 | 1.95378359 |
19 | PDK2 | 1.94606667 |
20 | SGK2 | 1.93319578 |
21 | WNK4 | 1.89013655 |
22 | FGFR4 | 1.86585337 |
23 | TESK2 | 1.85741679 |
24 | ERBB4 | 1.76637269 |
25 | MAP3K2 | 1.74834687 |
26 | ERN1 | 1.59294316 |
27 | SGK3 | 1.58060032 |
28 | SGK494 | 1.54727862 |
29 | SGK223 | 1.54727862 |
30 | MAPK11 | 1.54273554 |
31 | ZAK | 1.54162541 |
32 | MET | 1.44310498 |
33 | MYLK | 1.35920797 |
34 | LATS1 | 1.34233184 |
35 | MAP4K1 | 1.33538408 |
36 | TXK | 1.28923038 |
37 | PIK3CA | 1.26675022 |
38 | DDR2 | 1.26642435 |
39 | RIPK4 | 1.25919547 |
40 | TNIK | 1.23035868 |
41 | PIK3CG | 1.22429944 |
42 | PRKAA2 | 1.21899163 |
43 | EPHB1 | 1.18681611 |
44 | PRPF4B | 1.17691354 |
45 | GRK1 | 1.16641404 |
46 | MATK | 1.13941342 |
47 | MAP3K7 | 1.11111603 |
48 | NEK9 | 1.02983408 |
49 | STK24 | 1.01763001 |
50 | NUAK1 | 1.01222949 |
51 | PINK1 | 1.00822126 |
52 | MAP3K1 | 1.00778777 |
53 | MAP2K7 | 1.00426897 |
54 | MST4 | 0.95145622 |
55 | BMPR2 | 0.92214587 |
56 | PIM1 | 0.91234347 |
57 | PDPK1 | 0.87927047 |
58 | ADRBK2 | 0.87873594 |
59 | TIE1 | 0.85576405 |
60 | MAP2K4 | 0.84319827 |
61 | IRAK4 | 0.82594492 |
62 | DYRK1B | 0.82203470 |
63 | JAK1 | 0.80624958 |
64 | NLK | 0.79869170 |
65 | BMPR1B | 0.79851545 |
66 | PRKAA1 | 0.79711267 |
67 | TYK2 | 0.79560072 |
68 | IKBKE | 0.77656212 |
69 | PRKG2 | 0.76955054 |
70 | CDK8 | 0.76340414 |
71 | ERBB2 | 0.74306481 |
72 | TGFBR2 | 0.73713354 |
73 | GRK6 | 0.72981417 |
74 | MAP3K13 | 0.72142837 |
75 | TEC | 0.72078082 |
76 | YES1 | 0.70862641 |
77 | PDK1 | 0.70168990 |
78 | CDC42BPA | 0.70118299 |
79 | MAP3K11 | 0.69833779 |
80 | TESK1 | 0.67954705 |
81 | PTK6 | 0.67391648 |
82 | EIF2AK2 | 0.67183450 |
83 | TAOK1 | 0.66021472 |
84 | ITK | 0.64206483 |
85 | CHUK | 0.63817545 |
86 | MAPK7 | 0.63747267 |
87 | LMTK2 | 0.63564001 |
88 | CAMK2G | 0.60352309 |
89 | EPHB2 | 0.57920649 |
90 | PRKCZ | 0.54242024 |
91 | PRKCQ | 0.52696525 |
92 | IRAK2 | 0.52547667 |
93 | IRAK1 | 0.52015713 |
94 | EPHA3 | 0.51966958 |
95 | IKBKB | 0.51938111 |
96 | KSR2 | 0.51489306 |
97 | EPHA4 | 0.50581887 |
98 | CSF1R | 0.50366093 |
99 | MAPK15 | 0.49527287 |
100 | MAP3K12 | 0.47970928 |
101 | PRKCE | 0.47449115 |
102 | TBK1 | 0.47136428 |
103 | PRKACG | 0.46051093 |
104 | MAPK4 | 0.44915990 |
105 | PRKCD | 0.44779557 |
106 | TAOK2 | 0.44430716 |
107 | SRC | 0.44376041 |
108 | FYN | 0.44012297 |
109 | FGFR2 | 0.43581756 |
110 | STK3 | 0.43325332 |
111 | GSK3A | 0.42472447 |
112 | MAP2K6 | 0.42349259 |
113 | SGK1 | 0.41635495 |
114 | BTK | 0.41176581 |
115 | RET | 0.41018267 |
116 | PKN1 | 0.40771670 |
117 | PRKCA | 0.40299489 |
118 | CAMK2D | 0.40155519 |
119 | PTK2 | 0.39765173 |
120 | NEK6 | 0.38173037 |
121 | JAK2 | 0.37404598 |
122 | FER | 0.37002450 |
123 | SYK | 0.36616489 |
124 | PDGFRA | 0.36524907 |
125 | KIT | 0.36270500 |
126 | DAPK2 | 0.35840588 |
127 | RIPK1 | 0.35377577 |
128 | CDK19 | 0.35078113 |
129 | MAP2K2 | 0.33343747 |
130 | CSK | 0.33257667 |
131 | CDK6 | 0.32998335 |
132 | ABL2 | 0.32551004 |
133 | CAMK2B | 0.32534698 |
134 | IGF1R | 0.31423023 |
135 | MAP3K3 | 0.31211336 |
136 | FGFR3 | 0.29445827 |
137 | CAMK4 | 0.29428926 |
138 | CDK3 | 0.29205074 |
139 | MARK3 | 0.29204559 |
140 | PAK4 | 0.29116986 |
141 | MAPK12 | 0.28874047 |
142 | MELK | 0.28082894 |
143 | TRIB3 | 0.24225436 |
144 | LYN | 0.22301169 |
145 | PRKACA | 0.21577054 |
146 | MAP3K8 | 0.21514455 |
147 | BMX | 0.20594366 |
148 | RPS6KA2 | 0.20190605 |
149 | LCK | 0.20015818 |
150 | MAPKAPK2 | 0.17057355 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.52577961 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33850641 |
3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.91157533 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.55900399 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53679385 |
6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.47524709 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45085898 |
8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41386972 |
9 | Peroxisome_Homo sapiens_hsa04146 | 2.37250164 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36957883 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34404373 |
12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32996408 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27983398 |
14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22950018 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.21935870 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.11480094 |
17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05956884 |
18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.02696113 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00651725 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.97893725 |
21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.96106818 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.94041407 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93745403 |
24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.91730482 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91223154 |
26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.86042759 |
27 | * Bile secretion_Homo sapiens_hsa04976 | 1.74712019 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.65514746 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61740589 |
30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60830490 |
31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55810785 |
32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55154221 |
33 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.47440034 |
34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46528529 |
35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45977789 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41985968 |
37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40438918 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40225217 |
39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34474902 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.30054767 |
41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29360835 |
42 | ABC transporters_Homo sapiens_hsa02010 | 1.27365029 |
43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26737619 |
44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26342626 |
45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25795196 |
46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23554929 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16124500 |
48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13350285 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11741620 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05796285 |
51 | Lysine degradation_Homo sapiens_hsa00310 | 1.02929445 |
52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99656037 |
53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99468545 |
54 | Mineral absorption_Homo sapiens_hsa04978 | 0.97912426 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97279114 |
56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96438509 |
57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92293120 |
58 | Asthma_Homo sapiens_hsa05310 | 0.88479554 |
59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84902760 |
60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84481725 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83595043 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75964481 |
63 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71068863 |
64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69606531 |
65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66665523 |
66 | Allograft rejection_Homo sapiens_hsa05330 | 0.62894412 |
67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59226313 |
68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57597600 |
69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54802835 |
70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53492838 |
71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52807627 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52645970 |
73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52338649 |
74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48424162 |
75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.47481637 |
76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43380857 |
77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43049385 |
78 | Renin secretion_Homo sapiens_hsa04924 | 0.41956515 |
79 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38193767 |
80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.35745879 |
81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35374744 |
82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34382182 |
83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32524580 |
84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32067706 |
85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30140316 |
86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.29376069 |
87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.28214833 |
88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22892991 |
89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22559937 |
90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20517566 |
91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20180137 |
92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.19790748 |
93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.19576148 |
94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.18292163 |
95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.15564895 |
96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15553502 |
97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.14561086 |
98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.14512024 |
99 | Insulin secretion_Homo sapiens_hsa04911 | 0.14446879 |
100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14179463 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.13058062 |
102 | Hepatitis C_Homo sapiens_hsa05160 | 0.10830599 |
103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10467355 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.09235625 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.08173712 |
106 | Tight junction_Homo sapiens_hsa04530 | 0.07887629 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07518779 |
108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.07496360 |
109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07276941 |
110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.05674712 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05124908 |
112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.04617688 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04559017 |
114 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.02837261 |
115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.02765136 |
116 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.02646511 |
117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.02546279 |
118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.02101618 |
119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.01459392 |
120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01424809 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0344471 |
122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0327344 |
123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0212023 |
124 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0131220 |
125 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0117343 |
126 | Gap junction_Homo sapiens_hsa04540 | -0.0079770 |
127 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0073144 |
128 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0025903 |